Kromek Group plc (AIM: KMK), a provider of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, announced on Tuesday that it has entered into a collaboration agreement with a global technology solutions provider to develop Cadmium Zinc Telluride (CZT) based detectors for photon counting computed tomography (CT) applications in medical imaging. The blue-chip partner serves over 100,000 customers globally, including healthcare.

In this collaboration, Kromek will integrate its CZT sensors with the partner's read-out electronics for optimal CT detection system performance. The project aims for commercialisation, with Kromek ensuring production capability aligns with increased commercial demand.

Headquartered in County Durham, UK, Kromek enhances life quality through innovative detection technology solutions in medical, security and industrial markets.

In medical imaging, Kromek's CZT platform aids disease detection, while in CBRN detection, the Group provides nuclear radiation solutions for homeland defense and security. Bio-security solutions, including automated systems to detect airborne pathogens, are also under development in the CBRN detection segment.